Interpretation of guidelines for the diagnosis and treatment of diabetes mellitus with hyperlipidemia combined with disease and syndrome
10.3760/cma.j.cn115398-20230329-00425
- VernacularTitle:《糖尿病合并高脂血症病证结合诊疗指南》解读
- Author:
Ziqi ZHAO
1
;
Yuntao MA
;
Pai PANG
;
Shentao WU
;
Qing NI
;
Bin WANG
Author Information
1. 天津中医药大学第一附属医院内分泌科 国家中医针灸临床医学研究中心，天津 300381
- Keywords:
Diabetes mellitus;
Hyperlipidemias;
Combination with disease and syndrome;
Diagnostic and treatment guideline (TCMP);
Interpretation
- From:
International Journal of Traditional Chinese Medicine
2024;46(4):409-414
- CountryChina
- Language:Chinese
-
Abstract:
Along with the change in lifestyle and diet, diabetes mellitus with hyperlipidemia has been a major risk and death factor for cardiovascular disease with the increasing incidence of diabetes mellitus with hyperlipidemia year by year. In order to promote and make full use of unique characteristics and advantages of TCM, the guidance writing group adopted the pattern of combination with disease and syndrome to make a standardized approach to diagnosis and treatment based on emphasis on diagnosis and treatment. Guidelines for the Diagnosis and Treatment of Diabetes Mellitus with Hyperlipidemia Combined with Disease and Syndrome (hereinafter referred to as " the Guideline") was published in the World Chinese Medicine in August, 2021. Based on the pattern of combination with disease and syndrome, the Guideline highlights the significant characteristics, such as: precise diagnosis and treatment by combined with disease and syndrome, updating criteria, rehabilitation diet therapy and exercise and following the principles which include but not limited to evidence-based medicine. According to the evidence of evidence-based medicine and expert consensus, the Guideline gives recommendations for diagnosis, treatment and rehabilitation of diabetes mellitus with hyperlipidemia. In the article, the main contents and characteristics of the new guideline were interpreted in order to provide concise and practical guidance for clinicians and promote the clinical popularization and application of the Guideline.
